Document:

Prepared and filed by St Ives Financial

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933. IN ADDITION, THESE SECURITIES ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 9 OF THIS WARRANT.

WARRANT

To Purchase Shares of the capital stock of

MEDECISION, INC.

dated as of May 25, 2000

1. GRANT OF THE RIGHT TO PURCHASE STOCK.

a. For value received, and pursuant to the terms of the Note and Warrant Purchase Agreement dated May 25, 2000 among MEDecision, Inc. (the “Company”) and the other parties thereto (the “Purchase Agreement”), the Company hereby grants to Liberty Ventures I, L.P. (“Warrantholder”) the right, and the Warrantholder is entitled, upon the terms and subject to the conditions hereinafter set forth, to subscribe for and purchase from the Company, 12,000 fully paid and non-assessable shares (the “Shares”) of the Common Stock of the Company (the “Common Stock”) (the “Warrant”). The Exercise Price for the Shares issuable upon the exercise of this Warrant shall be $5.00 per share.

b. Only a single exercise of this Warrant shall be permitted, and such exercise shall be for the full number of Shares or other property into which this Warrant shall be exercisable at such time. Upon exercise and the issuance of such Shares or other property all other rights hereunder shall expire.

2. EXERCISE OF WARRANT

a. Notice of Exercise. The purchase rights set forth in this Warrant are exercisable by the Warrantholder at any time prior to the expiration of the term set forth in Section 3 of this Agreement by tendering to the Company at its principal office a notice of exercise in the form attached hereto as Annex I (the “Notice of Exercise”), duly completed and executed. Upon receipt of the Notice of Exercise and the payment of the Exercise Price in accordance with the terms of Section 2(b) or (c) of this Agreement, the Company shall issue to the Warrantholder a certificate for the number of Shares purchased and shall execute the Acknowledgment of Exercise indication that no Shares remain subject to future purchases.

 

b. Payment of Exercise Price. Payment of the Exercise shall be made (i) in cash or bank check payable to the order of the Company, or by wire transfer; or (ii) in the manner provided in Section 2(c) of this Agreement.

c. Net Issuance Rights. Warrantholder may exercise its rights to receive the Shares on a net basis, such that, without the exchange of any funds and upon surrender of the Warrant, the Warrantholder receives Shares equal to the value (as determined below) of this Warrant by surrender of the Warrant at the principal office of the Company together with notice of such election in which event the Company shall issue to the Warrantholder a number of Shares computed using the following formula:

X = Y(A-B)

  	
         

      	
        A
 

Where: X = the number of Shares to be issued to the Warrantholder.

Y = the number of Shares subject to this Warrant.

A = the fair market value of each Share (as determined by the Board of Directors).

B = Exercise Price.

3.
  TERM OF WARRANT. Except as otherwise provided for herein, the term of this Warrant
  and the right to purchase Shares as granted herein shall commence on the date
  of execution hereof and shall be exercisable until the earlier of (i) the closing
  of a Qualified Public Offering as defined in the Term Sheet (attached as Exhibit
  D to the Purchase Agreement), or (ii) May 24, 2007.

4. RESERVATION OF SHARES. During the term of this Warrant, the Company will at all times have authorized and reserved a sufficient number of Shares to provide for the exercise of the rights to purchase Shares as provided herein.

5. NO FRACTIONAL SHARES. No fractional shares representing fractional shares shall be issued upon the exercise of the Warrantholder’s rights to purchase Shares, but in lieu of such fractional shares the Company shall make a cash payment therefor.

6. ADJUSTMENT RIGHTS. The exercise price per share and the number of shares of Common Stock purchasable hereunder shall be subject to adjustment as follows:

a. Stock Dividends. If the number of shares of Common Stock outstanding is increased by a stock dividend payable in shares of Common Stock or by a subdivision or split-up of shares of Common Stock, then, following the record date fixed for the determination of holders of shares of Common Stock entitled to receive such stock dividend, subdivision or split-up, the exercise price shall be appropriately decreased so that the number of shares of Common Stock issuable upon exercise of this Warrant shall be increased in proportion to such increase in outstanding shares.

2

b. Stock Combination. If the number of shares of Common Stock outstanding is decreased by a combination of the shares of Common Stock then, following the record date for such combination, the exercise price shall be appropriately increased so that the number of shares of Common Stock issuable upon exercise of this Warrant shall be decreased in proportion to such decrease in outstanding shares.

c. Reclassification of Common Stock; Merger, Consolidation or Sale of Assets. In the event of any reclassification of the stock of the Company (other than a change in par value or from par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or combination of shares), or the merger, consolidation or sale of the Company (other than a consolidation or merger in which the Company is the continuing corporation and which does not result in any change in the shares of Common Stock), this Warrant shall after such reorganization, reclassification, merger, consolidation or sale represent the right to acquire the kind and number of shares of stock or other securities or property of the Company or of the corporation resulting from such merger,
consolidation or sale to which the holder of the number of shares of Common Stock deliverable (immediately prior to the time of such reorganization, reclassification, merger, consolidation or sale) upon exercise of the Warrant would have been entitled upon such reorganization, reclassification, merger, consolidation or sale. The provisions of this Section 6(c) shall similarly apply to successive reorganizations, reclassifications, mergers, consolidations, or sales.

d. Issuance of Common Shares at Less Than Exercise Price.

(i) If the Company shall issue any shares of Common Stock or other securities of the Company convertible into or exchangeable for shares of Common Stock (other than the Series B Preferred Stock issued pursuant to the Term Sheet or shares of Common Stock issued upon exercise of warrants issued under the Purchase Agreement, upon conversion of any outstanding shares of Series A Preferred Stock, upon exercise of warrants issued under a Note and Warrant Purchase Agreement between the Company and certain purchasers dated September 15, 1999, upon conversion of the Series B Preferred Stock or pursuant to the exercise of options to purchase Common Stock, such shares issuable upon exercise of options not to exceed in the aggregate 4,000,000 shares (appropriately adjusted to reflect stock splits, stock dividends, combination of shares and the like with respect to the Common Stock), or
(b) issued pursuant to a transaction which is described in Section 4.1(b)(iv)(C)(l)(f) or Section 4.1(b)(iv)(C)(l)(g) of the Company’s Articles of Incorporation or in connection with a strategic alliance or partnership entered into by the Company), without consideration or for a consideration per share less than the exercise price in effect immediately prior to such issuance, the exercise price in effect immediately prior to each such issuance shall forthwith be adjusted to a price equal to

  

	
       

    	
      A.

    	
      an
        amount equal to the sum of

    

(x) The total number of shares of Common Stock outstanding immediately prior to such issuance, multiplied by the exercise price in effect immediately prior to such issuance, plus

3

(y) the consideration received by the Company upon such issuance,

divided by

	
         

      	

B.
 	

the total number of shares of Common Stock outstanding immediately after the issuance of such shares of Common Stock.
 

(ii) No adjustment shall be made under this Section 6(d) upon the issuance of shares of Common Stock pursuant to the exercise, conversion or exchange of other securities of the Company if any such adjustment shall previously have been made under this Section 6(d) or was not required pursuant to this Section 6(d).

7. NO RIGHTS AS SHAREHOLDERS. This Warrant does not entitle the Warrantholder to any voting rights or other rights as a shareholder of the Company prior to the exercise of the Warrantholder’s rights to purchase Shares as provided for herein. No provision of this Warrant, in the absence of affirmative action by the Warrantholder to purchase Shares, and no enumeration in this Warrant of the rights or privileges of the Warrantholder, will give rise to any liability of such Warrantholder for the Exercise Price of the Shares acquirable by exercise hereof or as a stockholder of the Company.

8. WARRANTHOLDER REGISTRY. The Company shall maintain a registry showing the name and address of the registered holder of this Warrant.

9. TRANSFERS.

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933. IN ADDITION, THESE SECURITIES ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN THIS SECTION 9.

4

a. Subject to the restrictions, terms and conditions contained in this Section 9, this Warrant and all rights hereunder are transferable in whole or in part by the Warrantholder and any successor transferee; provided, however, that in no event shall the number of transfers of the rights and interests in all of the Warrant exceed 3 transfers, excluding transfers to Warrantholder’s parent or a majority owned subsidiary of Warrantholder’s parent or Warrantholder who takes subject to the restrictions contained herein. The transfer shall be recorded on the books of the Company upon receipt by the Company of a notice of transfer in the form attached hereto as Annex II (the “Transfer Notice”) at its principal offices and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer.

b. Legends. The Warrantholder agrees that the Company may place or cause to be placed on this Warrant and the certificates representing the Shares any appropriate legend or legends containing restrictions on transfer necessary under the Act and any other applicable state corporations or securities statutes and regulations, including the legend appearing at the beginning of this Agreement.

10. MISCELLANEOUS.

a. Effective Date. The provisions of this Warrant shall be construed and shall be given effect in all respects as if it had been executed and delivered by the Company on the date hereof. This Warrant shall be binding upon any successors or assigns of the Warrantholder and the Company.

b. Attorney’s Fees. In any litigation, arbitration or court proceeding between the Company and the Warrantholder relating hereto, the prevailing party shall be entitled to reasonable attorneys’ fees and expenses and all costs of proceedings incurred in enforcing this Warrant; provided, however, that (i) the liability of each Warrantholder under this Section 10(b) shall be limited to the outstanding principal amount of the Demand Notes issued by the Company to such Warrantholder under the Purchase Agreement, and (ii) the liability of the Company to a Warrantholder under this Section 10(b) shall be limited to the principal amount of the Demand Notes issued by the Company to such Warrantholder under the Purchase Agreement.

c. Governing Law. This Warrant shall be governed by and construed for all purposes under and in accordance with the laws of the Commonwealth of Pennsylvania.

d. Counterparts. This Warrant may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

e. Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be deemed effectively given upon personal delivery, or on the fifth day following mailing by registered or certified mail, return receipt requested, postage paid, or within one day of being sent by reputable overnight courier, addressed (i) to the Warrantholder at the address, telephone number and fax number set forth for the Warrantholder in the Purchase Agreement, and (ii) to the Company at 724 W. Lancaster Avenue, Suite 200, Wayne, PA 19087, Attention: Chief Executive Officer, or at such other address as any such party may subsequently designate by written notice to the other party.

5

f.
  Specific Performance.
  The Company recognizes and agrees that the Warrantholder may not have an adequate
  remedy if the Company fails to comply with this Agreement and that damages may
  not be readily ascertainable, and the Company expressly agrees that, in the
  event of such failure, it shall not oppose an application by the Warrantholder
  or any other person entitled to the benefit of this Agreement requiring specific
  performance of any or all provisions hereof or enjoining the Company from continuing
  to commit any such breach of this Agreement.

g. Survival. The representations, warranties, covenants and conditions of the respective parties contained herein or made pursuant to this Warrant shall survive the execution and delivery of this Warrant.

h. Severability. In the event any one or more of the provisions of this Warrant shall for any reason be held invalid, illegal or unenforceable, the remaining provisions of this Warrant shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, legal and enforceable provision, which comes closest to the intention of the parties underlying the invalid, illegal or unenforceable provision.

i. Amendments. Any provision of this Warrant may be amended by a written instrument signed by the Company and by the Warrantholder.

j. Representations of the Company. The Company hereby makes to the Warrantholder each of the representations, warranties and covenants set forth in the Purchase Agreement, subject to the applicable limitations set forth therein.

IN WITNESS WHEREOF, the parties hereto have caused this Warrant to be executed by its officers thereunto duly authorized.

 

	

Dated: May 25, 2000
 	

Company:
 
	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

MEDECISION, INC.
 
	

 
 	

 
 	

  
 	

 
 	

By: 
 	

      /s/ David St. Clair
      
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
	

 
 	

 
 	

 
 	

 
 	

Title:
 	

CEO
 
	

 
 	

 
 	

 
 	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

Warrantholder:
 
	

 
 	

 
 	

 
 	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

Liberty Ventures I, L.P.

	

 
 	

 
 	

  
 	

 
 	

  By: 
 	

/s/ Thomas R. Morse 
 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
	

 
 	

 
 	

 
 	

 
 	

Title:
 	

President, Liberty Ventures, Inc.

  Managing General Partner
 
	

 
 	

 
 	

 
 	

 
 	

 
 	

6

Annex
  I

NOTICE OF EXERCISE

To: ___________________

	

(1)
 	

The undersigned Warrantholder hereby elects to purchase shares of _________ of MEDecision, Inc. (the “Shares”), pursuant to the terms of the Warrant dated the ______ day of ________, 2000 (the “Warrant”) between MEDecision, Inc. and the Warrantholder.
 

	

(2)
 	

In exercising its rights to purchase the Shares, the undersigned hereby confirms and acknowledges the investment representations and warranties made in Section 8 of the Warrant.
 

	

(3)
 	

Please issue a certificate or certificates representing said Shares in the name of the undersigned or in such other name as is specified below.
 

 

  	
         

      	
         

      	
         

      	
         

      	
         

      
	
         

      	
         

      	
         

      	
         

      	
        
        

      
	
         

      	
         

      	
         

      	
         

      	
        (Name)

      
	
         

      	
         

      	
         

      	
         

      	
         

      
	
         

      	
         

      	
         

      	
         

      	
         

      
	
         

      	
         

      	
         

      	
         

      	
        
        

      
	
         

      	
         

      	
         

      	
         

      	
        (Address)

      
	 	 	 	 	 	 
	
         

      	
         

      	
         

      	
         

      	
        Warrantholder:

      	
        
        

      
	
         

      	
         

      	
         

      	
         

      	
         

      	
        
        

      

 

	

 
 	

 
 	

 
 	

 
 	

By: 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

Title:
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

Date:
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 

7

 

ACKNOWLEDGMENT OF EXERCISE

The undersigned _______________________, hereby acknowledges receipt of the “Notice of Exercise” from _________________________, to purchase _____________________ shares of the Common Stock of MEDecision, Inc., pursuant to the terms of the Warrant, and further acknowledges that no shares remain subject to purchase under the terms of the Warrant.

 

	

 
 	

 
 	

 
 	

 
 	

Company: MEDECISION, INC.
 
	

 
 	

 
 	

 
 	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

By: 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

Title:
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

Date:
 	

 
 
	

 
 	

 
 	

 
 	

 
 	

 
 	

 

8

Annex II

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933. IN ADDITION, THE WARRANT IS SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 8 OF THE WARRANT.

TRANSFER NOTICE

(To transfer or assign the foregoing Warrant execute this form and supply required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby transferred and assigned to

 

	

 
 
	

 
	

(Please Print)
 

 

  	
        whose
          address is 

      	

 
 
	

 
 	

 
	

 
 	

 
 
	

 
 
	

 

 

  	
         
 	

Dated
 	
         
 
	

 
 	

 
 	

 

 

  	

 
 	
        Warrantholder’s Signature
 	

 
 
	

 
 	

 
 	

 
	

 
 	

 
 	

 
 
	

 
 	

Warrantholder’s Address
 	

 
 
	

 
 	

 
 	

 
	

 
 	

 
 	

 
 
	

 
 	

 
 
	

 
 	

 
	

 
 	

 
 	

 
 

  	Signature Guaranteed:	
	
         

      	
        

      
	 	 

1. NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

9Prepared and filed by St Ives Financial

AMENDMENT TO WARRANTS TO PURCHASE SHARES OF THE CAPITAL STOCK

OF MEDECISION, INC. 

THIS AMENDMENT TO WARRANTS TO PURCHASE SHARES OF THE CAPITAL STOCK OF MEDECISION, INC. (the “Amendment”) is made on July 21, 2006, by and between MEDecision, Inc., a Pennsylvania corporation (the “Company”), and Liberty Ventures I, L.P. (the “Warrantholder”), and amends each of the following Warrants to Purchase Shares of the Capital Stock of MEDecision, Inc. that were issued to the Warrantholder pursuant to the terms of the Note and Warrant Purchase Agreement dated September 15, 1999 among the Company and the other parties thereto and the Note and Warrant Purchase Agreement dated May 25, 2000 among the
Company and the other parties thereto: (A) Warrant to Purchase Shares of the Capital Stock of MEDecision, Inc. dated as of September 15, 1999; (B) Warrant to Purchase Shares of the Capital Stock of MEDecision, Inc. dated as of September 30, 1999; (C) Warrant to Purchase Shares of the Capital Stock of MEDecision, Inc. dated as of October 28, 1999; (D) Warrant to Purchase Shares of the Capital Stock of MEDecision, Inc. dated as of December 17, 1999; (E) Warrant to Purchase Shares of the Capital Stock of MEDecision, Inc. dated as of March 10, 2000; (F) Warrant to Purchase Shares of the Capital Stock of MEDecision, Inc. dated as of April 13, 2000; and (G) Warrant to Purchase Shares of the Capital Stock of MEDecision, Inc. dated as of May 25, 2000 (each, a “Warrant”, and collectively, the “Warrants”).

BACKGROUND

The Company and the Warrantholder desire to amend each of the Warrants so as to ratify and confirm the definition of “Qualified Public Offering” in each of the Warrants, as set forth below.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Warrantholder, intending to be legally bound hereby, agree as follows:

1. Each Warrant is amended to add a new section following Section 10 of each Warrant as follows: 

“11. DEFINITIONS. For purposes of this Warrant, the term “Qualified Public Offering” shall mean the closing of the first public sale of the Common Stock of the Company pursuant to an effective registration statement under the Securities Act of 1933, as amended, for the account of the Company resulting in proceeds to the Company of not less than Thirty Million Dollars ($30,000,000) and as to which the public offering price per share of Common Stock multiplied by the number of fully diluted shares of Common Stock outstanding immediately prior to closing of the offering shall equal not less than One Hundred Fifty Million Dollars ($150,000,000).” 

 

2. This Amendment shall be binding upon any successors or assigns of the Warrantholder and the Company. 

3. This Amendment shall be governed by and construed for all purposes under and in accordance with the laws of the Commonwealth of Pennsylvania.

4. Except as expressly waived, amended, modified or supplemented hereby, each of the Warrants and the respective rights and obligations of each party thereto which are provided therein are hereby ratified and confirmed and shall continue in full force and effect. This Amendment shall not be considered a waiver or amendment of any party’s rights under any of the Warrants, except as the same are expressly waived, amended or supplemented hereby.

5. This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS]

-2-

 

IN WITNESS WHEREOF, the undersigned have caused this Amendment to be executed on the date first written above.

 

  	 	
         

      	
        MEDECISION,
          INC.

      
	
        
        

      	
         

      	
        By: 

      	
        

          /s/ Carl E. Smith

      
	
         

      	
         

      	
         

      	
        
        

      
	
         

      	
         

      	
         

      	
        Carl
          E. Smith

      
	
         

      	
         

      	
         

      	
        Chief
          Financial Officer

      

 

  	
         
 	

 
 	

LIBERTY VENTURES I, L.P.
 
	

 
 	

 
 	
        By:
 	
        Liberty Ventures, Inc.
 
	

 
 	

 
 	

Its:
 	

General Partner
 

 

  	
        
        

      	
         

      	
        By: 

      	
        

          /s/ Thomas R. Morse

      
	
         

      	
         

      	
         

      	
        
        

      
	
         

      	
         

      	
        Name:

      	
        Thomas
          R. Morse

      
	
         

      	
         

      	
        Title:

      	
        President

      

-3-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]